Department of Medicine, University of Southern California, Los Angeles, CA, USA.
Lipids Health Dis. 2014 Jan 8;13:8. doi: 10.1186/1476-511X-13-8.
HDL carries a rich protein cargo and examining HDL protein composition promises to improve our understanding of its functions. Conventional mass spectrometry methods can be lengthy and difficult to extend to large populations. In addition, without prior enrichment of the sample, the ability of these methods to detect low abundance proteins is limited. Our objective was to develop a high-throughput approach to examine HDL protein composition applicable to diabetes and cardiovascular disease (CVD).
We optimized two multiplexed assays to examine HDL proteins using a quantitative immunoassay (Multi-Analyte Profiling- MAP) and mass spectrometric-based quantitative proteomics (Multiple Reaction Monitoring-MRM). We screened HDL proteins using human xMAP (90 protein panel) and MRM (56 protein panel). We extended the application of these two methods to HDL isolated from a group of participants with diabetes and prior cardiovascular events and a group of non-diabetic controls.
We were able to quantitate 69 HDL proteins using MAP and 32 proteins using MRM. For several common proteins, the use of MRM and MAP was highly correlated (p < 0.01). Using MAP, several low abundance proteins implicated in atherosclerosis and inflammation were found on HDL. On the other hand, MRM allowed the examination of several HDL proteins not available by MAP.
MAP and MRM offer a sensitive and high-throughput approach to examine changes in HDL proteins in diabetes and CVD. This approach can be used to measure the presented HDL proteins in large clinical studies.
高密度脂蛋白(HDL)携带丰富的蛋白质组,研究 HDL 蛋白组成有望提高我们对其功能的理解。传统的质谱方法可能冗长且难以扩展到大量人群。此外,如果不对样本进行预先富集,这些方法检测低丰度蛋白质的能力将受到限制。我们的目标是开发一种高通量方法来检测适用于糖尿病和心血管疾病(CVD)的 HDL 蛋白组成。
我们使用定量免疫分析(Multi-Analyte Profiling-MAP)和基于质谱的定量蛋白质组学(Multiple Reaction Monitoring-MRM)优化了两种检测 HDL 蛋白的多重分析方法。我们使用人类 xMAP(90 蛋白面板)和 MRM(56 蛋白面板)筛选 HDL 蛋白。我们将这两种方法的应用扩展到一组患有糖尿病和先前心血管事件的参与者以及一组非糖尿病对照者的 HDL 中。
我们使用 MAP 定量了 69 种 HDL 蛋白,使用 MRM 定量了 32 种蛋白。对于几种常见蛋白,MRM 和 MAP 的使用高度相关(p<0.01)。使用 MAP,我们在 HDL 上发现了几种与动脉粥样硬化和炎症有关的低丰度蛋白。另一方面,MRM 允许检查 MAP 不可用的几种 HDL 蛋白。
MAP 和 MRM 提供了一种敏感且高通量的方法来检测糖尿病和 CVD 中 HDL 蛋白的变化。这种方法可用于在大型临床研究中测量所提出的 HDL 蛋白。